Loading clinical trials...
Loading clinical trials...
Alzheimer's Tau Platform (ATP): Regimen Specific Appendix for AADvac1
Conditions
Interventions
AADvac1
Donanemab
Start Date
June 30, 2026
Primary Completion Date
August 31, 2028
Completion Date
August 31, 2028
Last Updated
April 6, 2026
NCT07545473
NCT07531732
NCT07290387
NCT06121544
NCT06657768
NCT07178210
Lead Sponsor
Paul S. Aisen
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions